Class Action MVP: Bernstein Litowitz's Salvatore Graziano
As co-lead counsel for a class of investors accusing Merck & Co. and subsidiary Schering-Plough of concealing test results for their anti-cholesterol drug Vytorin from investors, Salvatore J. Graziano of Bernstein...To view the full article, register now.
Already a subscriber? Click here to view full article